Top compounds associated with response to ANAPC15


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA paclitaxel GDSC1000 pan-cancer AAC -0.026 0.6
mRNA PLX4720 CCLE pan-cancer AAC -0.022 0.6
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC -0.017 0.6
mRNA OSI-027 GDSC1000 pan-cancer AAC 0.015 0.6
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.017 0.6
mRNA BRD-K14844214 CTRPv2 pan-cancer AAC 0.019 0.6
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.6
mRNA paclitaxel CCLE pan-cancer AAC 0.022 0.6
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.018 0.6
Download CSV